Policy|Trade|Healthcare|Pharma — Trump Admin To Impose 100% Tariff On Generic Drugs Starting Aug 2028

The Trump administration will levy a 100% tariff on all generic pharmaceuticals beginning in August 2028, a move intended to incentivize the reshoring of drug manufacturing to the U.S. The decision follows over a year of internal debate regarding the potential impact on the low-cost drug market. This policy extends the administration's previous tariffs, which had targeted name-brand pharmaceuticals while leaving generics untouched for later consideration.